Rifabutin: compared to rifabutin administered alone (300 mg once daily), plasma rifabutin AUC (0- 48) was unchanged and Cmax was decreased 14% following co-administration of reduced doses of rifabutin (150 mg every other day) with fosamprenavir 700 mg twice daily with ritonavir 100 mg twice daily.